Reed momentum continues in first quarter

Publishing and events group Reed Elsevier reported that good momentum has continued through the first quarter and that growth was in line with last year.

Publishing and events group Reed Elsevier reported that good momentum has continued through the first quarter and that growth was in line with last year.

The group's dominant scientific, technical and medical arm is on track to deliver another year of 'modest' growth, but the legal arm, second largest by revenue in 2012, sees limited scope for growth with customer markets subdued.

Good growth is expected in both risk solutions and business information units, although some uncertainty continues to dog the former.

The exhibitions division, the smallest by sales in 2012, is in a cycling-out year with fewer biennial shows so despite 5-6% lower revenues, good growth is expect in US and Japan to compensate for a weak Europe.

Reed stated that it continued to make good progress on its strategy to transform the business into a "professional information solutions provider" and to improve the quality of earnings through organic development, with the portfolio also continuing to evolve through several acquisitions and disposals already so far in the three months to the end of March.

With cash generation strong, so far £181m of the promised £400m of share buybacks have been completed, with balance sheet further improved with the replacement of high coupon debt with a new bond issue.

OH

Recommended

Three sustainable stocks that are doing well by doing good
Share tips

Three sustainable stocks that are doing well by doing good

Professional investor Peter Michaelis of the Liontrust Sustainable Investment Team picks three stocks to buy that are helping to create a cleaner, saf…
26 Jul 2021
Share tips of the week – 23 July
Share tips

Share tips of the week – 23 July

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
23 Jul 2021
Will Zoom’s $15bn purchase help it expand?
Tech stocks

Will Zoom’s $15bn purchase help it expand?

The videoconferencing platform became a household name during the pandemic, but it now needs new sources of growth. Alex Rankine reports
23 Jul 2021
Philip Morris goes “beyond nicotine”
Stocks and shares

Philip Morris goes “beyond nicotine”

US tobacco giant Philip Morris International has agreed to pay £1bn for British inhaler specialist Vectura.
23 Jul 2021

Most Popular

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism
Economy

The MoneyWeek Podcast: Asia, financial repression and the nature of capitalism

Russell Napier talks to Merryn about financial repression – or "stealing money from old people slowly" – plus how Asian capitalism is taking over in t…
16 Jul 2021
Why the UK's 2.5% inflation is a big deal
Inflation

Why the UK's 2.5% inflation is a big deal

After years of inflation being a financial-assets problem, it is now an “ordinary things” problem too, says Merryn Somerset Webb. But central banks st…
16 Jul 2021
Commodity supercycle or not, here’s a metal that’ll still be in demand – tin
Industrial metals

Commodity supercycle or not, here’s a metal that’ll still be in demand – tin

Commodity prices may have come off the boil recently. But for tin, the only way is up. Dominic Frisby picks the best ways to invest.
7 Jul 2021